MetaCap

Pfizer Inc. (PFE)

NYSE: PFEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

27.40-0.14 (-0.51%)

At close: Nov 20, 4:02 PM ET · Delayed 15 min

PFE stock chart

Technical analysis

Key statistics

All statistics
Market cap
$156.18B
Dividend yield
7.85% ($2.15)
Ex-dividend date
Nov 6, 2026
52-week range
23.62 – 31.44
Day range
27.36 – 28.11
Volume / Avg
38.29M / 33.52M
Beta
—

52-week range

$23.62$31.44

PFE stock today

On Nov 20, PFE ended the session at $27.40, shedding $0.14 (0.51%), versus the S&P 500's 3.70% decline. Shares are 12.8% below their 52-week high of $31.44, set on Nov 5, 2026 and 16.0% above the 52-week low of $23.62, in the middle of the past year's range. PFE is up 10.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 9.4%.

At 39.1x trailing earnings, Pfizer trades above the peer-group median of 20.4x. Its forward P/E of 9.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Pfizer pays an annual dividend of $2.15 per share, a 7.85% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Pfizer

Company profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Albert Bourla D.V.M., Ph.D.
Headquarters
New York, NY
Employees
75,000
Website
pfizer.com

Financial highlights

Full financials

In fiscal 2025, Pfizer generated $62.58 billion in revenue, down 1.6% from fiscal 2024, its first annual decline since 2023. Net income was $7.77 billion (-3.2% year over year), for a net margin of 12.4% versus a median of 22.0% in the prior 5 years. Gross margin was 74.3% (up from 71.9%).

Pfizer annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$62.58B$63.63B$59.55B$101.17B$81.29B
Growth-1.65%+6.84%-41.14%+24.46%+95.16%
Net income$7.77B$8.03B$2.12B$31.37B$21.98B
EPS (diluted)$1.36$1.41$0.37$5.47$3.85

Analyst forecast

Forecast

Consensus (28 analysts)

buy

Avg. price target

$30.22+10.29%

  • Strong buy 1
  • Buy 8
  • Hold 17
  • Sell 1
  • Strong sell 1

Target range

Low $25.00High $37.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 3, 2026
EPS actual vs est.
$0.56 vs $0.72
Surprise
-22.22%

Dividends

Dividend history
Annual dividend
$2.15
Last payment
$0.43
Ex-dividend date
Nov 6, 2026

PFE news

All PFE news

Pfizer peers

Health Care sector
PFE peer companies
CompanyPrice% ChgMarket capCompare
NVONovo Nordisk A/S37.82-2.70%$166.69Bvs PFE
ABTAbbott Laboratories103.00-0.84%$178.39Bvs PFE
VRTXVertex Pharmaceuticals Incorporated515.02-1.08%$130.58Bvs PFE
BMYBristol-Myers Squibb Company58.80+0.79%$120.19Bvs PFE
SNYSanofi ADS46.52+1.00%$111.70Bvs PFE
GSKGSK plc ADR47.76-0.13%$95.73Bvs PFE
REGNRegeneron Pharmaceuticals Inc.920.69-0.19%$95.24Bvs PFE
TAKTakeda Pharmaceutical Company Limited ADR21.77+1.68%$69.55Bvs PFE

Indexes, lists and sector

Pfizer stock FAQ

What is Pfizer's stock price today?

PFE last traded at $27.40 as of Nov 20, 4:02 PM EST, down 0.51% on the day. Prices are delayed at least 15 minutes.

Does Pfizer pay a dividend?

Yes. Pfizer pays $2.15 per share annually, a 7.85% yield. The most recent dividend of $0.43 had an ex-dividend date of Nov 6, 2026.

What is PFE's P/E ratio?

PFE trades at a trailing P/E ratio of 39.14 and a forward P/E of 9.28, compared with a median of 20.4 for its closest peers.

Is Pfizer in the S&P 500?

Yes. Pfizer (PFE) is a constituent of the S&P 500 index.

Who is Pfizer's CEO?

Dr. Albert Bourla D.V.M., Ph.D. is the chief executive officer of Pfizer Inc., which has about 75,000 employees.

Has PFE ever split its stock?

Yes. The most recent PFE stock split was a 1054-for-1000 split on Nov 17, 2020, one of 6 splits on record.

What is the PFE 52-week high?

The 52-week high for PFE is $31.44 and the 52-week low is $23.62. The stock is currently 12.8% below its high.

Compare PFE